Josef Kapfhammer

Josef Kapfhammer

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2002 in Nature Genetics
Verified
Journal Article
Closed access
TMTheo Mantamadiotis
Theo Mantamadiotis
TLThomas Lemberger
Thomas Lemberger
SBSusanne C. Bleckmann
Susanne C. Bleckmann
HKHeidrun Kern
Heidrun Kern
OKOliver Kretz
Oliver Kretz
GSGünther Schütz
Günther Schütz

8 February 1994 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
JKJosef Kapfhammer
Josef Kapfhammer
MSMartin E. Schwab
Martin E. Schwab

1 November 2004 in Progress in Histochemistry and Cytochemistry
Verified
Journal Article
Closed access
JKJosef Kapfhammer
Josef Kapfhammer

1 June 2000 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
FMFriedrich Metzger
Friedrich Metzger
JKJosef Kapfhammer
Josef Kapfhammer

16 August 2007 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JKJosef Kapfhammer
Josef Kapfhammer
HXHong Xu
Hong Xu
JRJonathan A Raper
Jonathan A Raper

21 March 2007 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
KBKerstin Bendfeldt
Kerstin Bendfeldt
VRVesna Radojevic
Vesna Radojevic
JKJosef Kapfhammer
Josef Kapfhammer
CNCordula Nitsch
Cordula Nitsch
This study was performed to examine the maintenance of blood vesselsin vitroin cortical organotypic slice cultures of mice with special emphasis on basic fibroblast growth factor (FGF-2), which is known to promote angiogenesis and to preserve the integrity of the blood–brain barrier. Slices of neonatal day 3 or 4 mouse brain were maintained for 3, 7, or 10 din vitro(DIV) under standard culture conditions or in the presence of FGF-2. Immunohistochemistry for factor VIII-related antigen or laminin revealed a relative low number of blood vessels under standard conditions. In contrast, moderate FGF-2 concentrations increased the number of vessels: with 0.5 ng/ml FGF-2 it was 1.4-fold higher after DIV 3 or 1.5-fold after DIV 7 compared with controls; with 5 ng/ml it was almost doubled in both cases. With an excess of 50 ng/ml, FGF-2 vessels were reduced after DIV 3 or similar to controls after DIV 7. FGF receptor 1 was preferentially found on endothelial cells; its immunolabeling was reduced in the presence of the ligand. Cell death detected by an ethidium bromide analog or the apoptosis marker caspase-3 was barely detectable during the 10 d culture period. Immunolabeling of the tight junction proteins ZO-1 (zonula occludens protein 1), occludin, claudin-5, and claudin-3 revealed evidence for structural integrity of the blood–brain barrier in the presence of moderate FGF-2 concentrations. In conclusion, FGF-2 maintains blood vesselsin vitroand preserves the composition of the tight junction. Hence, we propose FGF-2-treated organotypic cortical slices as a new tool for mechanistic studies of the blood–brain barrier.